Deciphering the Functional Mechanisms of eIF3f in Tumors and Exploring Targeted Therapies
Pharmacology Research & Perspectives · 2026-08 · 14 (4)
DOI: 10.1002/prp2.70292 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmacology Research & Perspectives, online erschienen am 01.07.2026. Verfasst von Yujinpeng Hao und 3 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Eukaryotic Initiation Factor-3, Neoplasms, Antineoplastic Agents. Die Arbeit nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Natural Science Research Project of Jiangsu Higher Education Institutions.
Abstract (Originalsprache)
Eukaryotic translation initiation factor 3 subunit F (eIF3f) is a critical component of the eIF3 complex and plays a pivotal role in diverse biological processes, including cell proliferation, apoptosis, adhesion, and transcriptional regulation. Recent studies have revealed that eIF3f is aberrantly expressed in multiple malignancies and exhibits a striking context‐dependent functional profile. In solid tumors such as hepatocellular carcinoma (HCC), colorectal cancer (CRC), and prostate cancer (PCa), elevated eIF3f expression correlates with poor patient prognosis, indicating an oncogenic role. Conversely, in pancreatic cancer (PC) and melanoma (MM), reduced or absent eIF3f expression promotes tumor progression, suggesting a tumor‐suppressive function. This functional plasticity indicates that eIF3f is not a simple oncogenic driver but rather a molecular hub that integrates diverse cellular signals. This review systematically delineates the structural characteristics and biological functions of eIF3f, summarizing its expression patterns and underlying molecular mechanisms across various malignancies. Building on this, we propose an integrated mechanistic framework that attributes the functional plasticity of eIF3f to differential upstream signaling networks, heterogeneity in post‐translational modification profiles, and the remodeling status of the tumor microenvironment (TME). Furthermore, we critically evaluate the strength of evidence supporting eIF3f as a diagnostic and prognostic biomarker, identify methodological bottlenecks and translational challenges in current targeting strategies, and outline priority research directions, including elucidating the structural biological basis of its functional plasticity and developing context‐specific intervention strategies. By integrating mechanistic insights with clinical relevance, this review aims to establish a conceptually coherent and mechanistically testable theoretical framework for eIF3f research, guiding the design of precision stratified therapeutic approaches and facilitating its substantive translation from basic research to clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Clinical College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
- School of Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
ORCID-Profile: Yujinpeng Hao, Jun Shao, Naqi Lian, Mianli Bian
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Natural Science Research Project of Jiangsu Higher Education Institutions
- Provincial College Students' Innovation and Entrepreneurship Training Program
Zitieren
APA
Hao, Y., Shao, J., Lian, N., & Bian, M. (2026). Deciphering the Functional Mechanisms of eIF3f in Tumors and Exploring Targeted Therapies. Pharmacology Research & Perspectives, 14(4). https://doi.org/10.1002/prp2.70292
Vancouver
Hao Y, Shao J, Lian N, Bian M. Deciphering the Functional Mechanisms of eIF3f in Tumors and Exploring Targeted Therapies. Pharmacology Research & Perspectives. 2026;14(4). doi:10.1002/prp2.70292
BibTeX
@article{Hao2026,
author = {Hao, Yujinpeng and Shao, Jun and Lian, Naqi and Bian, Mianli},
title = {Deciphering the Functional Mechanisms of eIF3f in Tumors and Exploring Targeted Therapies},
journal = {Pharmacology Research & Perspectives},
year = {2026},
volume = {14},
number = {4},
doi = {10.1002/prp2.70292}
}
EUVIMED